CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China

Heng Meng, Rui Xiong, Ruyuan He, +11

Journal of Infection

Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury

Ruyuan He, Bohao Liu, Rui Xiong, +9

Cell Death Discovery

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Lin Zhang, Zhihua Geng, Bo Hao, +1

Cancer Control

Lymphoid NeoplasiaMedicineImmunologyTumor ImmunityCell Death +13

Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma

Bo Hao, Huixing Dong, Rui Xiong, +4

Computers in Biology and Medicine

Prognostic BiomarkersMedicineImmunologyPathologyCancer Genomics +6

Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis

Bo Hao, Zhen Chen, Baochen Bi, +8

Oncotarget

Dyslipidemia and non-small cell lung cancer risk in Chinese population: a case-control study

Bo Hao, Miaomei Yu, Chen Sang, +2

Lipids in Health and Disease

Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma

Bo Hao, Ziyao Zhang, Zilong Lu, +13

Translational Oncology

The prognostic value of tumor-stromal ratio combined with TNM staging system in esophagus squamous cell carcinoma

Ruyuan He, Donghang Li, Bohao Liu, +11

Journal of Cancer

Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma

Tao Fan, Shize Pan, Shuo Yang, +4

Frontiers in Immunology

Lung AdenocarcinomaImmunologyImmunoeditingPathologyGene Expression Omnibus +18

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma

Shize Pan, Heng Meng, Tao Fan, +5

Frontiers in Genetics

Lung AdenocarcinomaImmunologyPathologyCell DeathPcd Genes +15